Gati, Asma <br/><br/>
CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.  [electronic resource] 

 -  Cancer research  Nov 2003 
 - 7475-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--immunology<br/>Antibody Specificity<br/>CD3 Complex--immunology<br/>Carcinoma, Renal Cell--immunology<br/>Cell Death--immunology<br/>Down-Regulation<br/>Humans<br/>Kidney Neoplasms--immunology<br/>Lymphocyte Activation<br/>Receptors, Immunologic--immunology<br/>Receptors, KIR<br/>Receptors, KIR2DL1<br/>Signal Transduction--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Tumor Cells, Cultured<br/>fas Receptor--immunology